PreditX® is built by a multidisciplinary leadership team combining life sciences strategy, computational chemistry, and AI/ML expertise. Together, the team is developing a target-based AI drug discovery platform for small-molecule candidate prioritization.
Founder and CEO
Accomplished life sciences leader with more than 17 years of experience across pharmaceutical, consulting, and strategic leadership roles. Jorge leads the business vision of Pharmaeconomica and PreditX®, connecting scientific innovation with practical industry value.
Co-founder and CSO
Computational chemist with more than 10 years of experience in molecular modeling, AI-driven drug discovery, and hit-to-lead workflows. Usman leads the scientific strategy of PreditX®, with strong expertise in machine learning, structural biology, and computational chemistry.
Co-founder and Director AI/ML
Bioinformatician and AI/ML specialist with expertise in proteomics software, computational structural biology, and in silico protein analysis. Kanzal leads advanced AI/ML development across the PreditX® platform, helping translate scientific data into scalable product intelligence.
Our goal is to help research teams move from biological target selection to ranked, reviewable small-molecule candidates through a workflow that is computationally strong, operationally practical, and easy to use.
What the team combines
Life sciences strategy and market understanding
Computational chemistry and drug discovery expertise
AI/ML development and bioinformatics capability
Product-oriented execution for cloud-based workflows